REMEDA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 188,781 | 229,477 | 369,158 | 308,407 | 548,963 | 344,487 | 187,852 | 682,791 |
| Profit before tax | -13,087 | -40,175 | 2,454 | -27,498 | 5,730 | -46,825 | -64,114 | - |
| Net profit | -13,087 | -40,175 | 2,344 | -27,498 | 3,879 | -46,825 | -64,114 | 18,059 |
| Equity | 498,922 | 458,747 | 461,091 | 433,593 | 437,472 | 390,647 | 218,358 | 236,417 |
| Liabilities | 35,126 | 31,023 | 5,124 | 533 | 60,040 | 51,252 | 2,635 | 111,445 |
| Non-current assets | 14,866 | 10,961 | 7,990 | 6,364 | 5,718 | 2,456 | 1,782 | 500 |
| Current assets | 519,182 | 478,809 | 458,225 | 427,762 | 491,794 | 439,443 | 219,211 | 347,362 |
| Total assets | 534,048 | 489,770 | 466,215 | 434,126 | 497,512 | 441,899 | 220,993 | 347,862 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 143,529 | 57,173 | 153,287 |
| Social insurance contributions | - | - | - | - | - | 31,399 | 25,558 | 27,484 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -22.5% | +21.6% | +60.9% | -16.5% | +78.0% | -37.2% | -45.5% | +263.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.5% | -8.2% | 0.5% | -6.3% | 0.8% | -10.6% | -29.0% | 5.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -2.6% | -8.8% | 0.5% | -6.3% | 0.9% | -12.0% | -29.4% | 7.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -6.9% | -17.5% | 0.6% | -8.9% | 0.7% | -13.6% | -34.1% | 2.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -6.9% | -17.5% | 0.7% | -8.9% | 1.0% | -13.6% | -34.1% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 42,743 | 45,895 | 73,832 | 61,681 | 109,793 | 68,897 | 37,570 | 136,558 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
REMEDA - Social security debts
The company had no debts to Sodra
REMEDA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
REMEDA, UAB (code 120421972) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of EUR 682.8K and net profit of EUR 18.1K, corresponding to a 2.6% profit margin. This marked a strong rebound after 2024, when revenue fell to EUR 187.9K and the company posted a net loss of EUR 64.1K, following revenue of EUR 344.5K and a net loss of EUR 46.8K in 2023. Revenue growth in 2025 was 263.5% year on year and 98.2% over two years. The balance sheet strengthened in 2025, with total assets of EUR 347.9K, equity of EUR 236.4K and liabilities of EUR 111.4K. The equity ratio was 68.0% and debt-to-equity stood at 0.47. Asset turnover reached 1.96x, while ROE was 7.6% and ROA 5.2%. Revenue per employee was EUR 136.6K, and profit per employee EUR 3.6K.